Standout Papers

SARS-CoV-2 and Coronaviru... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
    2020 539 citations Firas Rabi, Mazhar Salim Al Zoubi et al. Pathogens profile →

Immediate Impact

57 hit
Sub-graph 1 of 23

Citing Papers

Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
2025 Hit
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
2025 Hit
1 intermediate paper

Works of Firas Rabi being referenced

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
2021

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Firas Rabi 362 89 88 50 50 8 579
Jaegyun Lim 443 1.2× 144 1.6× 59 0.7× 51 1.0× 44 0.9× 10 578
Sang-Joon Park 384 1.1× 138 1.6× 99 1.1× 42 0.8× 36 0.7× 6 566
Harsha Ganesan 254 0.7× 55 0.6× 140 1.6× 39 0.8× 41 0.8× 12 691
F. Akter 401 1.1× 60 0.7× 98 1.1× 39 0.8× 70 1.4× 5 548
Leila Mousavizadeh 484 1.3× 98 1.1× 145 1.6× 23 0.5× 42 0.8× 9 676
Isra Ahmad Farouk 236 0.7× 76 0.9× 90 1.0× 34 0.7× 39 0.8× 4 509
Wang Jun Lee 390 1.1× 155 1.7× 58 0.7× 57 1.1× 38 0.8× 5 517
Jianyong Zhu 405 1.1× 89 1.0× 137 1.6× 30 0.6× 35 0.7× 15 698
Xihua Lian 291 0.8× 55 0.6× 120 1.4× 25 0.5× 37 0.7× 18 544
Xiaoshan Su 268 0.7× 54 0.6× 142 1.6× 24 0.5× 37 0.7× 14 578

All Works

Loading papers...

Rankless by CCL
2026